TMCnet - World's Largest Communications and Technology Community



ECCRT, a SynteractHCR Company, Recognized as an Accredited Training Facility by TransCelerate BioPharma Inc.
[April 08, 2014]

ECCRT, a SynteractHCR Company, Recognized as an Accredited Training Facility by TransCelerate BioPharma Inc.

SAN DIEGO --(Business Wire)--

The European Centre for Clinical Research Training (ECCRT), a SynteractHCR company, has been recognized by TransCelerate BioPharma Inc. as an official training facility that meets the standards established for investigator training by this association of biopharma companies.

TransCelerate BioPharma Inc. is a non-profit organization focused on advancing innovation in research and development (R&D), identifying and solving common R&D challenges, and further improving patient safety, with the goal of delivering more high quality medicines to patients. It has established several clinical data standards, including study site qualification and training. Once accredited by the organization, ECCRT is recognized by all members of the organization as an approved training facility for investigators - which in turn, means that all investigators trained by this facility meet the standards established.

"SynteractHCR and its training facility are dedicated to supporting even higher levels of proficiency in the industry," says Gerald Van Roey, M.Ph.Ed., managing director at ECCRT. "To achieve this end, it was imperative for us to be acknowledged as an industry-recognized site for investigator training. Training is an important investment for companies, and one that will pay off in the long-run, in having both more engaged employees and better patient care."

TransCelerate evolved from discussions at various forums for executive R&D leadership to discuss relevant issues facing the industry and solutions for addressing common challenges. SynteractHCR supports the goal of this organization to enhance focus on qualitative training based on good course design, correct methodology and Good Clinical Practice. As part of its ICD+ initiative, SynteractHCR seeks out ways to increase efficiencies, streamline process and improve outcomes; ECCRT's recognition by TransCelerate meets the goals of the organization as well as that of its parent company.

About SynteractHCR (

SynteractHCR is a full-service contract research organization with a successful two-decade track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development. SynteractHCR has conducted Phase I-IV studies on six continents and in more than 50 countries, offering expertise across multiple therapeutic areas and with notable depth in oncology, CNS, infectious disease, endocrinology, cardiovascular and respiratory, among other indications. With its "Shared Work - Shared Vision" philosophy and ICD+ approach, SynteractHCR provides customized services collaboratively and cost effectively, ensuring on-time delivery of quality data so clients get to decision points faster.

[ Back To's Homepage ]

Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments:
Comments about this site:


© 2018 Technology Marketing Corporation. All rights reserved | Privacy Policy